ArticleProteome science2012

A comparative proteomic study identified LRPPRC and MCM7 as putative actors in imatinib mesylate cross-resistance in Lucena cell line.

Stephany Corrêa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.